Modern treatment of patients at risk: still a HOPE for ACE inhibitors?

Author： Angeli Fabio   Reboldi Gianpaolo   Verdecchia Paolo  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.6, 2011-04, pp. : 839-843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors reduce CV risk in patients with atherosclerosis

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk in Patients with Early Renal Insufficiency: Implications for the Use of ACE Inhibitors

By Mann J.F.E.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 157-162

Adis International

Access to resources Recommend Favorite

ACE inhibitors vs AIIRAs in diabetic nephropathy: jury still out

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Fetal exposure to ACE inhibitors: congenital malformation risk?

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Aspirin safe in patients with HF receiving ACE inhibitors

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite